THE EFFECTS OF MULTIPLE DRUG USE ON BALANCE, FALL RISK, AND COGNITIVE STATUS
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-99
SponsorOndokuz Mayıs University
About this trial
This study aims to evaluate the effects of polypharmacy on balance, fall risk, cognitive status, vestibular function, and hearing among individuals living in nursing homes. The study investigates the relationship between polypharmacy and balance, fall risk, cognitive, vestibular, and hearing-related outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals aged 60 years and older
Individuals living in nursing homes in Samsun
Individuals in the polypharmacy group using the defined number of medications and individuals in the control group using fewer or no medications
Ability to walk independently without an assistive device
Disqualifiers
Individuals younger than 60 years
Severe dementia
Use of an assistive walking device
Central nervous system or visual pathologies that may affect balance
Trial population
The study population consisted of individuals aged 60 years and older living in nursing homes in Samsun. Participants were divided into two groups according to medication use: a polypharmacy group and a control group. All participants were able to walk independently, communicate verbally, and complete the study assessments.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
50 Participants
are grouped into 2 trial groupsGroup A: Study Group
Group B: Control Group
Trial outcomes
Primary outcomes
1
Standardized Mini-Mental State Examination
Description: Individuals' cognitive status was assessed using the Standardized Mini-Mental State Examination and compared between the polypharmacy group and the control group.
Time frame
Baseline2
Cognitive-Vestibular Function Scale
Individuals' cognitive-vestibular functions were assessed using the Cognitive-Vestibular Function Scale and compared between the polypharmacy group and the control group.
Time frame
BaselineSecondary outcomes
1
6-Meter Walk Test
Description: Individuals' gait speed was assessed using the 6-Meter Walk Test and compared between the polypharmacy group and the control group.
Time frame
Baseline2
Functional Reach Test
Description: Individuals' dynamic balance and functional reach performance were assessed using the Functional Reach Test and compared between the polypharmacy group and the control group.
Time frame
Baseline3
Timed Up and Go Test
Description: Individuals' functional mobility and fall risk were assessed using the Timed Up and Go Test and compared between the polypharmacy group and the control group.
Time frame
Baseline4
Tinetti Balance and Gait Test
Description: Individuals' balance and gait performance were assessed using the Tinetti Balance and Gait Test and compared between the polypharmacy group and the control group.
Time frame
BaselineOther outcomes
1
Pure-Tone Audiometry Hearing Thresholds
Description: Hearing thresholds were assessed by pure-tone audiometry at 250, 500, 1000, 2000, and 4000 Hz in both ears and compared between the study and control groups.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: